35
Participants
Start Date
October 31, 2012
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2017
Stereotactic ablative radiotherapy
"The HCC patients with major portal vein tumor thrombosis (tumor thrombosis in the main portal vein or 1st branch of portal vein) will be included in this study. Total stereotactic ablative radiotherapy (SABR) doses will be 40 Gy in 4 fractionations. Patients receive 4 fractionations separated by \>48 hours.~At least 700 ml of normal liver (entire liver minus cumulative GTV) should not receive a total dose of \> 19.2 Gy in three fractions. If volume of normal liver does not exceed 700 ml, at least 70% of normal liver should not receive a total dose of \> 19.2 Gy. Dose of spinal cord do not exceed 26 Gy. Dose of esophagus, stomach and intestine do not exceed 35 Gy."
Gyeongsang National University Hospital, Jinju
Dongnam Institute of Radiological & Medical Sciences, Busan
Catholic University Incheon St. Mary's Hospital, Incheon
Inha University Hospital, Incheon
Soon Chun Hyang University Hospital Seoul, Seoul
Keimyung University Dongsan Medical Center, Daegu
Seoul National University Hospital, Seoul
Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul
Seoul National University Hospital
OTHER
Dongnam Institute of Radiological & Medical Sciences
OTHER
Soon Chun Hyang University
OTHER
Inha University Hospital
OTHER
Incheon St.Mary's Hospital
OTHER
Gyeongsang National University Hospital
OTHER
Keimyung University Dongsan Medical Center
OTHER
Korea Cancer Center Hospital
OTHER